Related references
Note: Only part of the references are listed.Antibody-drug conjugates in metastatic triple negative breast cancer: a spotlight on sacituzumab govitecan, ladiratuzumab vedotin, and trastuzumab deruxtecan
Julia E. McGuinness et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2021)
Antibiotics: From the Beginning to the Future: Part 1
Nancy Khardori et al.
INDIAN JOURNAL OF PEDIATRICS (2020)
Engineered antibody-functionalized porous silicon nanoparticles for therapeutic targeting of pro-survival pathway in endogenous neuroblasts after stroke
Vimalkumar Balasubramanian et al.
BIOMATERIALS (2020)
FDA Approval Summary: Ado-Trastuzumab Emtansine for the Adjuvant Treatment of HER2-positive Early Breast Cancer
Suparna Wedam et al.
CLINICAL CANCER RESEARCH (2020)
Bioorthogonal Tetrazine Carbamate Cleavage by Highly Reactive trans-Cyclooctene
Arthur H. A. M. van Onzen et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)
Autotransporter-Mediated Display of Complement Receptor Ligands by Gram-Negative Bacteria Increases Antibody Responses and Limits Disease Severity
Kristen M. Holland-Tummillo et al.
PATHOGENS (2020)
Improving efficacy of glycoconjugate vaccines: from chemical conjugates to next generation constructs
Francesco Berti et al.
CURRENT OPINION IN IMMUNOLOGY (2020)
Programmable multistage drug delivery to lymph nodes
Alex Schudel et al.
NATURE NANOTECHNOLOGY (2020)
Isonitrile-responsive and bioorthogonally removable tetrazine protecting groups
Julian Tu et al.
CHEMICAL SCIENCE (2020)
Synthetic carbohydrate-based vaccines: challenges and opportunities
Ravinder Mettu et al.
JOURNAL OF BIOMEDICAL SCIENCE (2020)
FDA Approval Summary: Brentuximab Vedotin in First-Line Treatment of Peripheral T-Cell Lymphoma
Nicholas C. Richardson et al.
ONCOLOGIST (2019)
Dendritic cell targeted Ccl3-and Xcl1-fusion DNA vaccines differ in induced immune responses and optimal delivery site
Anna Lysen et al.
SCIENTIFIC REPORTS (2019)
Development of Effective Therapeutics Targeting HER3 for Cancer Treatment
Xiaolong Liu et al.
BIOLOGICAL PROCEDURES ONLINE (2019)
Immunomodulatory properties of MSC-derived exosomes armed with high affinity aptamer toward mylein as a platform for reducing multiple sclerosis clinical score
Fazileh Hosseini Shamili et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Current and emerging avenues for Alzheimer's disease drug targets
R. Loera-Valencia et al.
JOURNAL OF INTERNAL MEDICINE (2019)
Lung Tissue Delivery of Virus-Like Particles Mediated by Macrolide Antibiotics
Stephen N. Crooke et al.
MOLECULAR PHARMACEUTICS (2019)
Targeting the transferrin receptor for brain drug delivery
Kasper Bendix Johnsen et al.
PROGRESS IN NEUROBIOLOGY (2019)
A promising bioconjugate vaccine against hypervirulent Klebsiella pneumoniae
Mario F. Feldman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Targeted Therapies for Triple-Negative Breast Cancer
Tomas G. Lyons
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2019)
Tuning Isonitrile/Tetrazine Chemistry for Accelerated Deprotection and Formation of Stable Conjugates
Minghao Xu et al.
JOURNAL OF ORGANIC CHEMISTRY (2019)
TP10-Dopamine Conjugate as a Potential Therapeutic Agent in the Treatment of Parkinson's Disease
Izabela Rusiecka et al.
BIOCONJUGATE CHEMISTRY (2019)
Novel HER2-Targeting Antibody-Drug Conjugates of Trastuzumab Beyond T-DM1 in Breast Cancer: Trastuzumab Deruxtecan(DS-8201a) and (Vic-)Trastuzumab Duocarmazine (SYD985)
Zhuyu Xu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Parkinson's Disease
Stephen G. Reich et al.
MEDICAL CLINICS OF NORTH AMERICA (2019)
Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers
Talar Tokatlian et al.
SCIENCE (2019)
Gold Nanoparticles with Antibiotic-Metallopolymers toward Broad-Spectrum Antibacterial Effects
Peng Yang et al.
ADVANCED HEALTHCARE MATERIALS (2019)
Abstract PD3-14: Phase 1 study of the antibody-drug conjugate SGN-LIV1A in patients with heavily pretreated triple-negative metastatic breast cancer
S Modi et al.
CANCER RESEARCH (2018)
Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional/herbal medicines in cancer therapy: a systematic review
Nadda Muhamad et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Bioorthogonal Removal of 3-Isocyanopropyl Groups Enables the Controlled Release of Fluorophores and Drugs in Vivo
Julian Tu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
FDA Approval Summary: Mylotarg for Treatment of Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia
Kelly J. Norsworthy et al.
ONCOLOGIST (2018)
Correlates of adjuvanticity: A review on adjuvants in licensed vaccines
Giuseppe Del Giudice et al.
SEMINARS IN IMMUNOLOGY (2018)
Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice
Raffaella Rossin et al.
NATURE COMMUNICATIONS (2018)
Multidrug-Resistant Pseudomonas Infections: Hard to Treat, But Hope on the Horizon?
Lynn Nguyen et al.
CURRENT INFECTIOUS DISEASE REPORTS (2018)
Curcumin-loaded PLGA-PEG nanoparticles conjugated with B6 peptide for potential use in Alzheimer's disease
Shengnuo Fan et al.
DRUG DELIVERY (2018)
Cholera: Immunity and Prospects in Vaccine Development
Jason B. Harris
JOURNAL OF INFECTIOUS DISEASES (2018)
Glycoconjugate vaccines: Principles and mechanisms
Rino Rappuoli
SCIENCE TRANSLATIONAL MEDICINE (2018)
Systems analysis of human vaccine adjuvants
Ali M. Harandi
SEMINARS IN IMMUNOLOGY (2018)
Bioengineering Strategies for Protein-Based Nanoparticles
Dennis Diaz et al.
GENES (2018)
Small Synthetic Peptides Bioconjugated to Hybrid Gold Nanoparticles Destroy Potentially Deadly Bacteria at Submicromolar Concentrations
Gianna Palmieri et al.
BIOCONJUGATE CHEMISTRY (2018)
Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25
Stephen W. Scally et al.
NATURE COMMUNICATIONS (2017)
Gold Nanoparticles Conjugated Levofloxacin: For Improved Antibacterial Activity Over Levofloxacin Alone
Paramdeep Bagga et al.
CURRENT DRUG DELIVERY (2017)
Enhancing vaccine antibody responses by targeting Clec9A on dendritic cells
Hae-Young Park et al.
NPJ VACCINES (2017)
Nanoassembly routes stimulate conflicting antibody quantity and quality for transmission-blocking malaria vaccines
Darren B. Leneghan et al.
SCIENTIFIC REPORTS (2017)
Inotuzumab Ozogamicin: First Global Approval
Yvette N. Lamb
DRUGS (2017)
Inverse electron demand Diels-Alder reactions in chemical biology
B. L. Oliveira et al.
CHEMICAL SOCIETY REVIEWS (2017)
Antibody-Drug Conjugates (ADCs) for Personalized Treatment of Solid Tumors: A Review
John M. Lambert et al.
ADVANCES IN THERAPY (2017)
Purification and characterization of a Shigella conjugate vaccine, produced by glycoengineering Escherichia coli
Neil Ravenscroft et al.
GLYCOBIOLOGY (2016)
Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study
Mark S. Riddle et al.
CLINICAL AND VACCINE IMMUNOLOGY (2016)
Bioconjugation and stabilisation of biomolecules in biosensors
Susana Liebana et al.
BIOSENSOR TECHNOLOGIES FOR DETECTION OF BIOMOLECULES (2016)
Complement resistance mechanisms of Klebsiella pneumoniae
Dennis J. Doorduijn et al.
IMMUNOBIOLOGY (2016)
Advances in Chemical Protein Modification
Omar Boutureira et al.
CHEMICAL REVIEWS (2015)
APC targeted micelle for enhanced intradermal delivery of hepatitis B DNA vaccine
Buddhadev Layek et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Novel antibody-antibiotic conjugate eliminates intracellular S. aureus
Sophie M. Lehar et al.
NATURE (2015)
The development and manufacture of influenza vaccines
Barry C. Buckland
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Pros and Cons of Antigen-Presenting Cell Targeted Tumor Vaccines
Cleo Goyvaerts et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
Vaccine Adjuvants: from 1920 to 2015 and Beyond
Alberta Di Pasquale et al.
VACCINES (2015)
Antibody- Drug Conjugates: An Emerging Concept in Cancer Therapy
Ravi V. J. Chari et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Nanoparticles and their applications in cell and molecular biology
Edina C. Wang et al.
INTEGRATIVE BIOLOGY (2014)
The molecular adjuvant mC3d enhances the immunogenicity of FimA from type I fimbriae of Salmonella enterica serovar Enteritidis
Hassan-Hussein Musa et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2014)
SGN-LIV1A: A Novel Antibody-Drug Conjugate Targeting LIV-1 for the Treatment of Metastatic Breast Cancer
Django Sussman et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Site-specific antibody drug conjugates for cancer therapy
Siler Panowski et al.
MABS (2014)
Protective immunity against enteral stages of Trichinella spiralis elicited in mice by live attenuated Salmonella vaccine that secretes a 30-mer parasite epitope fused to the molecular adjuvant C3d-P28
Ericka N. Pompa-Mera et al.
RESEARCH IN VETERINARY SCIENCE (2014)
STEAP1 is overexpressed in prostate cancer and prostatic intraepithelial neoplasia lesions, and it is positively associated with Gleason score
Ines M. Gomes et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
Dendritic cell-targeted vaccines
Lillian Cohn et al.
FRONTIERS IN IMMUNOLOGY (2014)
Click to Release: Instantaneous Doxorubicin Elimination upon Tetrazine Ligation
Ron M. Versteegen et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
DNA-Damaging Agents in Cancer Chemotherapy: Serendipity and Chemical Biology
Kahlin Cheung-Ong et al.
CHEMISTRY & BIOLOGY (2013)
Multiple mechanisms mediate enhanced immunity generated by mAb-inactivated F. tularensis immunogen
Bibiana V. Iglesias et al.
IMMUNOLOGY AND CELL BIOLOGY (2013)
The Specificity of Targeted Vaccines for APC Surface Molecules Influences the Immune Response Phenotype
Gunnveig Grodeland et al.
PLOS ONE (2013)
Medical Virology of Hepatitis B: how it began and where we are now
Wolfram H. Gerlich
VIROLOGY JOURNAL (2013)
DENV-2 subunit proteins fused to CR2 receptor-binding domain (P28)-induces specific and neutralizing antibodies to the Dengue virus in mice
Jazmin Garcia-Machorro et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Delivery of gold nanoparticles to the brain by conjugation with a peptide that recognizes the transferrin receptor
Roger Prades et al.
BIOMATERIALS (2012)
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A. -P. Magiorakos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Alum adjuvant: some of the tricks of the oldest adjuvant
Mirjam Kool et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2012)
Remyelination Induced by a DNA Aptamer in a Mouse Model of Multiple Sclerosis
Branislav Nastasijevic et al.
PLOS ONE (2012)
Zinc and Cancer: Implications for LIV-1 in Breast Cancer
Bruce J. Grattan et al.
NUTRIENTS (2012)
High CD33 expression levels in acute myeloid leukemia cells carrying the nucleophosmin (NPM1) mutation
Maria Stefania De Propris et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Bacterial Toxin-Triggered Drug Release from Gold Nanoparticle-Stabilized Liposomes for the Treatment of Bacterial Infection
Dissaya Pornpattananangkul et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
Construction and immunogenicity of DNA vaccines encoding fusion protein of murine complement C3d-p28 and GP5 gene of porcine reproductive and respiratory syndrome virus
Deqing Zhang et al.
VACCINE (2011)
Nanoparticles: Emerging carriers for drug delivery
Sagar R. Mudshinge et al.
SAUDI PHARMACEUTICAL JOURNAL (2011)
Antibody-drug conjugates for cancer: poised to deliver?
Bethan Hughes
NATURE REVIEWS DRUG DISCOVERY (2010)
Origins and Evolution of Antibiotic Resistance
Julian Davies et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2010)
Enhancement of anti-DIII antibodies by the C3d derivative P28 results in lower viral titers and augments protection in mice
Matthew D. Dunn et al.
VIROLOGY JOURNAL (2010)
Fc receptor-targeted mucosal vaccination as a novel strategy for the generation of enhanced immunity against mucosal and non-mucosal pathogens
Edmund J. Gosselin et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2009)
Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin
David Sancho et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Utilization of Fc receptors as a mucosal vaccine strategy against an intracellular bacterium, Francisella tularensis
Deepak B. Rawool et al.
JOURNAL OF IMMUNOLOGY (2008)
Mechanism of the cell-penetrating peptide transportan 10 permeation of lipid bilayers
Lindsay E. Yandek et al.
BIOPHYSICAL JOURNAL (2007)
A bacterial carbohydrate links innate and adaptive responses through Toll-like receptor 2
Qun Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
In vivo targeting of dendritic cells for activation of cellular immunity using vaccine carriers based on pH-responsive microparticles
YJ Kwon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis
S Gelperina et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Engineering N-linked protein glycosylation with diverse O antigen lipopolysaccharide structures in Escherichia coli
MF Feldman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Contribution of C3d-P28 repeats to enhancement of immune responses against HBV-preS2/S induced by gene immunization
Li-Xin Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2004)
Cutting edge: C3d functions as a molecular adjuvant in the absence of CD21/35 expression
KM Haas et al.
JOURNAL OF IMMUNOLOGY (2004)
Enhancement of antibodies to the human immunodeficiency virus type 1 envelope by using the molecular adjuvant C3d
TD Green et al.
JOURNAL OF VIROLOGY (2003)
N-linked glycosylation in Campylobacter jejuni and its functional transfer into E-coli
M Wacker et al.
SCIENCE (2002)
Increased immunogenicity and induction of class switching by conjugation of complement C3d to pneumococcal serotype 14 capsular polysaccharide
ST Test et al.
INFECTION AND IMMUNITY (2001)
Recombinant human adenovirus: Targeting to the human transferrin receptor improves gene transfer to brain microcapillary endothelium
HB Xia et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
